1. Home
  2. APRE vs DTSS Comparison

APRE vs DTSS Comparison

Compare APRE & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • DTSS
  • Stock Information
  • Founded
  • APRE 2006
  • DTSS 2014
  • Country
  • APRE United States
  • DTSS China
  • Employees
  • APRE N/A
  • DTSS N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • DTSS Computer Software: Prepackaged Software
  • Sector
  • APRE Health Care
  • DTSS Technology
  • Exchange
  • APRE Nasdaq
  • DTSS Nasdaq
  • Market Cap
  • APRE 21.3M
  • DTSS 17.9M
  • IPO Year
  • APRE 2019
  • DTSS N/A
  • Fundamental
  • Price
  • APRE $2.92
  • DTSS $2.47
  • Analyst Decision
  • APRE Strong Buy
  • DTSS
  • Analyst Count
  • APRE 2
  • DTSS 0
  • Target Price
  • APRE $15.50
  • DTSS N/A
  • AVG Volume (30 Days)
  • APRE 13.3K
  • DTSS 128.1K
  • Earning Date
  • APRE 11-07-2024
  • DTSS 11-13-2024
  • Dividend Yield
  • APRE N/A
  • DTSS N/A
  • EPS Growth
  • APRE N/A
  • DTSS N/A
  • EPS
  • APRE N/A
  • DTSS N/A
  • Revenue
  • APRE $1,310,839.00
  • DTSS $38,176,218.00
  • Revenue This Year
  • APRE $116.72
  • DTSS N/A
  • Revenue Next Year
  • APRE N/A
  • DTSS N/A
  • P/E Ratio
  • APRE N/A
  • DTSS N/A
  • Revenue Growth
  • APRE 130.31
  • DTSS 174.14
  • 52 Week Low
  • APRE $2.15
  • DTSS $1.42
  • 52 Week High
  • APRE $8.85
  • DTSS $20.29
  • Technical
  • Relative Strength Index (RSI)
  • APRE 34.50
  • DTSS 55.00
  • Support Level
  • APRE $2.87
  • DTSS $2.30
  • Resistance Level
  • APRE $3.35
  • DTSS $3.00
  • Average True Range (ATR)
  • APRE 0.32
  • DTSS 0.25
  • MACD
  • APRE -0.12
  • DTSS -0.00
  • Stochastic Oscillator
  • APRE 4.50
  • DTSS 38.03

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About DTSS Datasea Inc.

Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.

Share on Social Networks: